40

Shares

How payers are tackling value-based drug pricing

Shared by Radhika Narayanan | 0 40 0 | about 1 year ago

A growing number of value-based drug pricing arrangements are tying the price of treatments to outcomes. While these payment models are far from prominent now, is it likely that drug makers will have a greater share of the risks and rewards associated with value-based care moving forward?

Read More On www.healthcaredive.com

Categories Digital chemistry & Pharma IT Payers & Providers

Related Post

Links

http://www.healthcaredive.com/news/how-payers-are-tackling-value-based-drug-pricing/429015/
http://www.healthcaredive.stfi.re/news/how-payers-are-tackling-value-based-drug-pricing/429015/?sf=aovnpbe
http://stfi.re/aovnpbe
http://bit.ly/2eU6RIw

1 Votes

You must log in to post a comment

0 Comments